The rise of mortality from mental and neurological diseases in Europe, 1979–2009: observational study

Abstract

BackgroundWe studied recent trends in mortality from seven mental and neurological conditions and their determinants in 41 European countries.MethodsAge-standardized mortality rates were analysed using standard methods of descriptive epidemiology, and were related to cultural, economic and health care indicators using regression analysis.ResultsRising mortality from mental and neurological conditions is seen in most European countries, and is mainly due to rising mortality from dementias. Mortality from psychoactive substance use and Parkinson’s disease has also risen in several countries. Mortality from dementias has risen particularly strongly in Finland, Iceland, Malta, Netherlands, Spain, Sweden and the United Kingdom, and is positively associated with self-expression values, average income, health care expenditure and life expectancy, but only the first has an independent effect.ConclusionsAlthough trends in mortality from dementias have probably been affected by changes in cause-of-death classification, the high level of mortality from these conditions in a number of vanguard countries suggests that it is now among the most frequent causes of death in high-income countries. Recognition of dementias as a cause of death, and/or refraining from life-saving treatment for patients with dementia, appear to be strongly dependent on cultural values.Electronic supplementary materialThe online version of this article (doi:10.1186/1471-2458-14-840) contains supplementary material, which is available to authorized users.

Trends in Non‐Hispanic White Mortality in the United States by Metropolitan‐Nonmetropolitan Status and Region, 1990–2016

“…These patterns may, in part, reflect regional differences in coding practices over time and substitution between cause of death categories (Taylor et al 2017). The increase in death rates from mental and neurological disorders, including Alzheimer's disease, is not unique to the United States, and has also been observed in several European countries (Mackenbach, Karanikolos, and Looman 2014;Ho and Hendi 2018).…”

Neuronal Stem Cell and Drug Interactions: A Systematic Review and Meta-Analysis: Concise Review

“…This number is expected to double in individuals of over 70 years . In addition, there has been a tremendous rise in the number of geriatric patients suffering from mental or neurological disorders during the last decade, which is even expected to increase as our population ages . Unfortunately, conventional pharmaceutical interventions for neurodegenerative diseases are often limited in efficacy .…”

Mortality of neurological disorders in Tanzania: analysis of baseline data from sample vital registration with verbal autopsy (SAVVY)

“…Dementia and Parkinson's disease are the most common ND in most developed countries with a reported increasing trend [1]. The increases in ND's mortality in developed countries are higher than increases in other chronic diseases such as cancer and diseases of circulation [2].…”